Koyfin Home > Directory > Health Care > Biogen Inc > Net Debt / (EBITDA-CAPEX)

Biogen Inc Net Debt / (EBITDA-CAPEX) Chart (BIIB)

Biogen Inc annual/quarterly Net Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Biogen Inc Net Debt / (EBITDA-CAPEX) for the quarter ending September 09, 2020 was $1m a 88.90% increase of 1m year over year
  • Biogen Inc Net Debt / (EBITDA-CAPEX) for the last 12 months ending September 09, 2020 was $0m a 84.02% increase of 0m year over year
  • Biogen Inc Annual Net Debt / (EBITDA-CAPEX) for 2019 was $0m a -114.96% decrease of 0m from 2018
  • Biogen Inc Annual Net Debt / (EBITDA-CAPEX) for 2018 was $0m a 185.95% increase of 0m from 2017
  • Biogen Inc Annual Net Debt / (EBITDA-CAPEX) for 2017 was $0m a -49.65% increase of 0m from 2016
Other Ratios Metrics:
  • Biogen Inc Total Debt / Capital for the quarter ending December 12, 2018 was $31m a 5.08% increase of 2m year over year
  • Biogen Inc Other Liabilities for the quarter ending December 12, 2018 was $3,026m a 1.80% increase of 55m year over year
  • Biogen Inc Total Debt / Equity for the quarter ending December 12, 2018 was $46m a 7.23% increase of 3m year over year
View Chart On Koyfin

Quarterly BIIB Net Debt / (EBITDA-CAPEX) Data

09/2020$1m
06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m

Annual BIIB Net Debt / (EBITDA-CAPEX) Data

2019$0m
2018$0m
2017$0m
2016$0m
2015$0m
2014$-1m
2013$0m
2012$-1m
2011$-1m
2010$0m